Momentum Started Last Month. This Month, It Took Command.

If May 2025 felt like the moment neurotechnology earned its legitimacy, June proved it wasn’t a fluke. The pace didn’t just continue. It intensified. We saw first-in-human data from some of the field’s most promising competitors, real signs of platform diversity beyond deep-brain implants, and a growing chorus of ethical voices demanding global governance around neural data.

This month was less about “look what’s possible,” and more about “here’s what’s already happening.”

I want to argue: Neurotech will soon enter the phase of productionization. For the first time, we’re seeing multiple parallel paths. Not just to market, but to patient lives.

Let’s walk through the biggest shifts that made June another historic chapter.

For years, Paradromics has been dubbed the quiet Neuralink competitor. This month, however, they made some noise.

In a successful procedure at the University of Michigan, Paradromics implanted its Connexus® brain-computer interface in a human for the first time. This wasn’t just a passive implant; it actively recorded high-fidelity brain signals via 400+ microelectrodes embedded in a small cortical array.

The goal? Restore speech and mobility for people with severe neurological injuries, beginning with locked-in patients.

Unlike Neuralink’s more experimental positioning, Paradromics has been laser-focused on clinical clarity, high-channel data resolution, and a transparent regulatory path. With first-in-human signals secured, their multi-participant clinical trial is underway.

One of the most important philosophical questions in BCI is how invasive it needs to be.

Precision Neuroscience, founded by former Neuralink cofounder Dr. Ben Rapoport, believes the answer is: not very.

In June, the company reaffirmed its commitment to surface-level cortical implants — ultra-thin electrode arrays that rest on top of the brain rather than penetrate it. These devices have shown strong early signals, and this month the company was recognized by Fast Company and Inc. as one of the world’s most promising and mission-driven companies.

By reducing invasiveness without compromising signal quality, Precision is carving out a middle path, one that could enable safer, faster, and more scalable deployment in hospitals worldwide.

From June 12–14, the Neural Interfaces 2025 conference brought together the world’s leading experts in neuromodulation and brain-computer interface.

It wasn’t a hype fest. It was practical. It was technical. It was global.

Themes included:

Neurotech is becoming a category, not just a research niche. There are now professional circuits, annual events, investor playbooks, and growing communities of practice.

As the tech progresses, so do the stakes.

In a powerful June cover story from The Australian, Synchron CEO Tom Oxley and ethicist Nita Farahany raised a red flag: without proper guardrails, neural data could become the most abused dataset in history.

Why? Because brain signals are identity. Emotions. Intent. Memories.

In response, policy movements are ramping up. The U.S. Congressional Committee on AI and Healthcare held an emergency session on cognitive rights. UNESCO followed up its May ethics draft with a proposal for global neural data standards. And multiple senators in the U.S. floated legislation that would classify neural data under HIPAA protections.

These are the early blueprints for brain-rights governance.

This wasn’t just another big month. It was a signal that BCI is not a winner-take-all space.

The neurotech stack is no longer one-track. It’s a branching forest of strategies, each offering different tradeoffs in precision, invasiveness, affordability, and control.

And for the first time, multiple players are executing their vision.

If you tuned in last month, you saw neurotech reach legitimacy.

If you’re tuning in now, you’re watching scale begin.

Whether you’re a founder, policymaker, researcher, or designer, this is no longer “a weird frontier.”

Until next time,—Daniel Kim

[1] Paradromics First-In-Human Recording: Paradromics, June 2, 2025[2] Precision Neuroscience Thin-Film Update: AOL, June 27, 2025[3] Neural Interfaces Conference Highlights: Neuralmodulation.org, June 12 - 14, 2025[4] Brain Privacy Interview with Tom Oxley: The Australian, June 2025[5] Congressional Hearings on Neural Data Protection: C-SPAN, June 2025[6] UNESCO Global Ethics Draft – June Revision: unesco.org, June 2025